logo

For the Inventor, By the Inventor

Carmel, IN, United States of America

Peter P Ho

This inventor holds 7 USPTO granted patents and 2 published patent applications. Top assignees: Eli Lilly and Company, London Hospital Medical College. Active years: 1977-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter P Ho. Retrieved from https://idiyas.com/inventor/peter-p-ho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 100.0

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 52(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1982)
  • Carmel, IN (US) (1977 - 1994)

Company Filing History:

goldMedal7 out of 4,522 
 
Eli Lilly and Company
 patents
silverMedal1 out of 6 
 
London Hospital Medical College
 patents
where one patent can have more than one assignee

Years Active: 1977-1994

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5294630 - Treatment of inflammatory bowel disease (1994-03-15),
2. 4863923 - Method of inhibiting superoxide release (1989-09-05),
3. 4617311 - Antiasthmatic method (1986-10-14),
4. 4552891 - Benzothiophene derivatives (1985-11-12),
5. 4322428 - 2(4-Fluorophenyl)-4,5,-bis(4-methoxyphenyl)thiazole and method of use (1982-03-30),
6. 4021553 - 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents (1977-05-03),
7. 4018923 - 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents (1977-04-19),

Title: A Look into the Innovations of Peter P. Ho

Introduction

Peter P. Ho, based in Carmel, IN, is an accomplished inventor known for his significant contributions to medical research and treatment. Holding seven patents to his name, he has made remarkable strides in the field of healthcare, particularly in the management of inflammatory diseases.

Latest Patents

Among his latest patents is a groundbreaking treatment for inflammatory bowel disease. This invention utilizes compounds from a series of 3-phenyl-5-carboxypyrazoles and isothiazoles to effectively treat the condition and protect patients from relapses into active disease. Furthermore, Peter has developed a method of inhibiting superoxide release, aimed at reducing tissue damage after inflammatory or ischemic events. This method employs versatile compounds such as benzothiophenes, benzofurans, and naphthalenes, marking a significant advancement in medical treatment protocols.

Career Highlights

Peter P. Ho has established a commendable career through his work with notable companies. He has contributed his expertise at Eli Lilly and Company, a leading pharmaceutical firm, as well as the London Hospital Medical College. His tenure at these institutions has provided him with a platform to innovate and lead in the field of medical research.

Collaborations

Throughout his career, Peter has collaborated with respected professionals in the field. Among his notable coworkers are Jill A. Panetta and William B. Lacefield, who have complemented his efforts with their own expertise and insight, further enhancing the quality of the innovations developed.

Conclusion

Peter P. Ho stands out as a noteworthy inventor in the medical domain, with a robust portfolio of patents that demonstrate his commitment to improving healthcare outcomes. His innovative approaches to treating inflammatory conditions exhibit not only his technical acumen but also his dedication to the betterment of patient health. As the landscape of medical research continues to evolve, Peter’s contributions will undoubtedly leave a lasting impact.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…